Palivizumab FDA Link

A humanized monoclonal antibody and ANTIVIRAL AGENT that is used to prevent RESPIRATORY SYNCYTIAL VIRUS INFECTIONS in high risk pediatric patients.

Also Known As:

MEDI 493; MEDI-493; Monoclonal Antibody MEDI-493; Synagis; MEDI493; Monoclonal Antibody MEDI 493; Monoclonal Antibody MEDI493

Surveillance Committee for Severe RSV Infection Selected Research

Surveillance Committee for Severe RSV Infection Research Topics